New York City, NY, USA - October 2024: Vincere Biosciences is pleased to attend the 16th annual Michael J. Fox Foundation (MJFF) Parkinson’s Disease Therapeutics Conference, taking place on October 17th, 2024, in New York City. The event remains the only conference in the world dedicated solely to Parkinson’s Disease (PD) drug development, bringing together over 300 experts from academia and industry to share and discuss the latest innovations in PD therapeutics.

Dublin, Ireland - June 2024: The Longevity Summit Dublin is an annual event focused on longevity research, rejuvenation biotechnology, and healthspan hosted by Aubrey De Grey and the Longevity Escape Velocity Foundation. A recording of this invited talk is now available on YouTube.

Cambridge, MA - September 2023: The National Institute of Neurological Disorders and Stroke has awarded Vincere Bio a Phase 1 SBIR grant to...

Boston, MA - September 2023: Vincere Biosciences, Inc has been selected as one of six finalists for the prestigious “Start Up of the Year” award presented by Biotech Week Boston (BWB). This award “recognizes a burgeoning company that has blossomed into an industry leader through growth and innovation.

Boston, MA - September 2023: Vincere Biosciences Co-Founder and CEO, Dr. Spring Behrouz and Co-Founder and COO, Andy Lee, will present at the 3rd Annual Mitochondria-Related Drug Development Summit. Dr. Behrouz will be giving a talk entitled “Targeting USP30 & Parkin: Boosting Mitophagy & Mitochondrial Quality Control as a Treatment Strategy for Neurodegenerative Disease,” discussing Vincere’s work on neurodegenerative diseases such as Parkinson’s disease. Mr. Lee will be leading a workshop on “Developing & Validating Preclinical Disease Models for Mitochondrial Diseases” alongside Marni Falk, Executive Director of the Mitochondrial Medicine Frontier Program at Children's Hospital of Philidelphia, Sherine Chan, CEO of Neuroene Therapeutics, and Karel Erion, Director of Preclinical Research at Capacity Bio.

Boston, MA - September 2023: Vincere Biosciences will be attending the RESI (Redefining Early Stage Investments) Conference, held in Boston. The event is a premier platform that bridges the gap between innovative startups and global investors across drugs, devices, diagnostics, and digital health sectors.

Cambridge, MA - June 2023: Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced the expansion of their open collaboration strategy by investing in Vincere Biosciences...

Boston, MA - June 2023: National Institute on Aging has sponsored Vincere Bio to present an update on Vincere's USP30 inhibitor programs at the 2023 BIO International Convention on Wednesday, June 7 2:30:00 PM in Room 104C. Vincere will have additional presence at the NIH Innovation Zone throughout the conference and be available for partnering via the BIO platform.

Birmingham, AL - June 2023: Spring Behrouz and Andy Lee will present to students and faculty on their expertise of entrepreneurship, data, and drug discovery. They will also join a panel of faculty for further discussions on the topics.

Boston, MA - May 2023: Spring Behrouz will join a panel with Deloitte and Atlas Venture to unravel the complexities of financing in today's ecosystem and share valuable insights on successfully raising capital

Scottsdale, AZ - May 2023: Spring Behrouz will be attending the summit on behalf of Vincere Bioscience to join industry leaders, academic-based and practicing KOLs, and investors for an engaging discussion on renal drug development.

Cambridge, MA - April 2023: Vincere Biosciences was selected as one of only three finalists to represent Tufts Launchpad BioLabs Boston in the 2023 Sanofi Golden Ticket Competition.

Gothenburg, Sweden - March 2023: Andy Lee was invited to present a poster at the 2023 AD/PD Conference sharing the recent developments of Vincere Bioscience’s work on VB-08 small molecule USP30 inhibitor.

Boston, MA - June 2022: Vincere Biosciences Inc initiates new in vivo studies for Parkinson's disease with new funding from the Michael J. Fox...

Copenhagan, Denmark - August 2022: Dr Sharifi was invited to present a poster sharing the longevity and healthspan potential of Vincere's USP30 inhibitor small molecules.

Boston, MA - June 2022: Vincere Biosciences Inc is expanding into cardiac and longevity indications with new funding from...

Boston, MA - May 2022: Andy Lee was invited to give a keynote address on application of systems biology in drug discovery.

Barcelona, Spain and online - March 2022: Dr. Spring Behrouz, Ph.D. will present a scientific update on Vincere's USP30 inhibitor program with a recorded virtual poster session.

Online - June 2021: Andy Lee was invited to give a keynote address on overcoming the lack of evidence for finding new drug candidates in drug discovery.

Online - April 2021: Dr. Spring Behrouz, Ph.D. was invited to speak in the Parkinson’s and Movement Disorders Panel during a live session on Therapeutics Day 2 on April 28 as part of the SACHS Associates' 4th Annual Neuroscience Innovation Forum (NIF). Vincere Biosciences was also featured during the conference’s Company Showcase for Business Development, Licensing & Investment from April 28 to April 30.

Cambridge - November 2020: Vincere Biosciences is pleased to be chosen as one of two winners of Bristol Myers Squibb’s 2020 Golden Tickets for LabCentral. The prize will cover the cost of one lab bench and one resident scientist fee at LabCentral’s Kendall Square facility for one year.

Online - September 2020: Dr. Spring Behrouz, Ph.D. represented Vincere Biosciences to pitch during the Entrepreneurship World Cup 2020, East Coast Semi-finals. Entrepreneurship World Cup is the world’s largest entrepreneurship ecosystem, with 199 participating countries, more than 150,000 entrepreneurs, and an annual competition to showcase the world’s most innovative startups.

Online - September 2020: Vincere Biosciences is slated to present alongside five other semifinalists during a pitch competition and investor panel hosted by JLABS.

Online - September 2020: Online - September 2020: Andy Lee will present a case study on Drug Discovery Models to Prioritize Pathways and Targets for Parkinson’s Disease during the AI Applications for Drug Discovery & Development Conference as part of the 13th annual Biopharm America and Biotech Week Boston.

Online - July 2020: Dr. Spring Behrouz Ph.D. presents alongside 3 leading researchers in the Parkinson Disease field on July 28 in a webinar titled, “Parkinson’s Disease: Genetics, Disease Mechanisms and Novel Therapeutic Targets.” The speakers will discuss new insights gleaned from the latest research in PD genetics, disease biology, and applications of the identification of PD-associated genes to drug discovery.

Cambridge, MA, USA - April 2020: Vincere Biosciences, Inc has been awarded a Phase I SBIR grant from the National Institute of Neurological Disorders and Stroke to develop inhibitors of USP30...

Santa Fe, NM - February 2020: Kalpana Merchant, Ph.D. gave a talk on technologies that de-risk and enable CNS drug discovery and development, in which she exemplified systems biology combined with NeuroInitiative's computational technology for target ID/validation and discussed the importance of engineering and validating flow scheme assays to garner confidence in the hits using the parkin activator program.

San Francisco, CA - January 2020: Spring Behrouz, PhD selected to present in the Seed Showcase during JPM on Wednesday January 15, 2020.

San Francisco, CA - January 2020: Spring Behrouz, PhD will present an introduction and data on Vincere's emerging small-molecule program targeting mitochondrial homeostasis during JPM on Sunday January 12, 2020.

Basel, Switzerland - December 2019: Andy Lee will present on Bridging the Gap Between Biology and Technology, sharing how Vincere has implemented unique computational tools and cross-functional teams to accelerate drug discovery.

Lincoln, MA - October 2019: Spring Behrouz, PhD will discuss "Biopharma's AI Scouts" on a panel moderated by Xconomy Editor in Chief Greg Huang.

Boston, MA - September 2019: Spring Behrouz, PhD will present an introduction and data on Vincere's emerging small-molecule program targeting mitochondrial homeostasis in room 252A at 1:30PM on September 11, 2019.

Cambridge, MA, USA - July 2019: Vincere Biosciences, Inc welcomes Dario Alessi, PhD, Stephen K. Burley, MD, DPhil, and Peter Lansbury, PhD to its Scientific Advisory Board...

Kyoto, Japan - June 2019: Kalpana Merchant, PhD will chair multiple panels and present on the process of taking a therapy from the lab, to the clinic, to the market.

Cambridge, MA, USA - May 2019: Vincere Biosciences, Inc has received a grant from the Michael J Fox Foundation to accelerate the development of small molecule activators...

Mainz, Germany - May 2019: Spring Behrouz, PhD will present the suite of computational drug discovery tools used by Vincere.

San Diego, CA - November 2018: Jason Hall, PhD will present a nansymposium talk entitled "In silico simulation of parkin cellular pathways: Elucidating mechanisms of Parkinson’s disease"

San Diego, CA - November 2018: Andy Lee will present a dynamic poster entitled "Converging pathways in genetic and sporadic Parkinson’s disease: Using unbiased network analysis to connect the dots"

Cambridge, MA, USA - October 2018: Vincere Biosciences, Inc, a Delaware corporation headquartered in Cambridge, MA was created to commercialize a series of therapeutic assets...